Drug-resistant Shigella bacteria on the rise in US, CDC study reveals: What to know

NBC New York reports on a CDC study published April 9 showing a nearly 8.5% increase in drug-resistant Shigella infections from 2011 to 2023, with the report noting that most extensively drug-resistant cases now occur in adult men rather than children, and approximately one-third of patients required hospitalization. The article provides a comprehensive health advisory format covering symptoms, transmission routes, at-risk populations, and prevention measures, all sourced directly to CDC guidance. Independent coverage from Fox News, CIDRAP, and Food Safety Magazine corroborates the 8.5% figure and broader trend, with CIDRAP adding important context that 47% of affected adult men had HIV—a detail absent from this NBC piece that would strengthen understanding of vulnerable populations. The article reads primarily as a public health resource rather than investigative reporting; no byline is visible in the metadata, and there are no quotes from CDC officials, epidemiologists, or healthcare providers beyond block quotes from official reports, limiting the depth of analysis about implications or response strategies.